Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
Brexit
UK Life Sciences Firms Struggle in Post-Brexit War for EU…
UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from overseas. Additionally, UK firms are looking to poach EMA staff as it heads to Amsterdam…
Brexit: Much ado about nothing?
Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…
Brexit: A Serious Threat to Patients
As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are…
In Conversation
Chris Fox – General Manager, Amgen UK & Ireland
Christine (Chris) Fox, VP and general manager UK and Ireland at Amgen, two months into her first country manager position and first time in a role outside of North America, discusses the creation of new, innovative partnership models with stakeholders across the healthcare spectrum, how Amgen is leveraging its biologic manufacturing expertise to move into biosimilars, and the importance of…
Brexit Facts & Figures Snapshot
There is much debate surrounding the potential impact on the UK’s life sciences industry of the…
Related Report
Brexit and Irish Pharma
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
Pfizer’s Nordkamp Takes ABPI Presidency
Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…
Brexit: A Window of Opportunity for France’s Drug Regulator?
As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…
Europe: Political Complexity Bodes Poorly for Pharma
Aditya Bhattacharji takes a look at the potentially damaging impact of political uncertainty across Europe –…
Roche boss: Brexit will make the UK less competitive
Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…
NEW Special Report on UK
Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…